These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3476118)

  • 1. Inhibition of constriction of cerebral arterioles in vivo by naftidrofuryl. Action against serotonin and dinoprost.
    Rosenblum WI
    Arzneimittelforschung; 1987 May; 37(5):495-7. PubMed ID: 3476118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and physiological evidences for antiserotonergic properties of naftidrofuryl.
    Maloteaux JM; Haiech J; De Campeneere D; Berta P; Vidal N
    Arzneimittelforschung; 1986 Aug; 36(8):1194-8. PubMed ID: 3022761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of naftidrofuryl on PGF2 alpha, U 46.619, 5-HT and thromboxane A2 (TXA2) induced vasoconstriction.
    Verheggen R; Schrör K
    Biomed Biochim Acta; 1988; 47(10-11):S264-7. PubMed ID: 3248112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of the spasmogenic effect of exogenous and endogenous serotonin on isolated blood vessels by naftidrofuryl].
    Verheggen R; Schrör K
    Vasa Suppl; 1988; 24():5-10. PubMed ID: 3212604
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of naftidrofuryl on adrenergic nerves, endothelium and smooth muscle in isolated canine blood vessels.
    Zander JF; Aarhus LL; Katusic ZS; Rubanyi GM; Vanhoutte PM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):760-7. PubMed ID: 3025417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effect of naftidrofuryl on 5-hydroxytryptamine-mediated constriction in rat peripheral microcirculation.
    Koch LG; Alsip NL; Feige BD; Wead WB; Harris PD
    Eur J Pharmacol; 1994 Mar; 254(3):249-55. PubMed ID: 8013559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic treatment with naftidrofuryl attenuates the development of vascular hypersensitivity to serotonin in the spontaneously hypertensive rat.
    Thorin E; Capdeville C; Trocklé G; Wiernsperger N; Atkinson J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S54-7. PubMed ID: 1369720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naftidrofuryl on the contraction and proliferation of cultured myocytes evoked by serotonin.
    Bodin P; Travo P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S25-8. PubMed ID: 1369713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of naftidrofuryl (praxilene) on the peripheral cerebral circulation. Dynamometric and dynamographic control].
    Barut C; Roch MT
    Bull Soc Ophtalmol Fr; 1974; 74(7-8):771-8. PubMed ID: 4469472
    [No Abstract]   [Full Text] [Related]  

  • 10. Naftidrofuryl inhibits contractions to serotonin in intact and de-endothelialized cerebral arteries in vitro.
    Oudart N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S45-8. PubMed ID: 1369718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of naftidrofuryl, a 5-HT2 antagonist, on collateral vascular responses to serotonin and to platelet activation.
    Hollenberg NK; Nie Q
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S36-9. PubMed ID: 1369716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of naftidrofuryl on the time course of the regional cerebral blood flow in acute ischemic stroke.
    Kobayashi S; Yamaguchi S; Katsube T; Okada K; Kitani M; Murao M; Tsunematsu T
    Arzneimittelforschung; 1984; 34(11):1580-3. PubMed ID: 6543134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin, 5-HT2 receptors, and their blockade by naftidrofuryl: a targeted therapy of vascular diseases.
    Wiernsperger NF
    J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S37-43. PubMed ID: 7517475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naftidrofuryl protects neurons against ischemic damage.
    Krieglstein J; Sauer D; Nuglisch J; Rossberg C; Beck T; Bielenberg GW; Mennel HD
    Eur Neurol; 1989; 29(4):224-8. PubMed ID: 2759148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of naftidrofuryl on platelet-induced vasospasm in vitro. Role of antiserotonergic actions.
    Verheggen R; Schrör K
    Arzneimittelforschung; 1993 Mar; 43(3):330-4. PubMed ID: 8489562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of naftidrofuryl on cerebral hemodynamics, metabolism and function after a retracted ischaemia.
    Le Poncin-Lafitte M; Grosdemouge C; Roy-Billon C; Duterte D; Rapin JR
    Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):218-29. PubMed ID: 7165427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation after naftidrofuryl application in vitro and ex vivo.
    Kirsten R; Erdeg B; Moxter D; Hesse K; Breidert M; Nelson K
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):81-4. PubMed ID: 7757315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of diabetes on microvascular responses in mouse mesentery.
    Rosenblum WI; Bryan D; Choi SC
    Microcirc Endothelium Lymphatics; 1985 Apr; 2(2):195-205. PubMed ID: 3836342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of naftidrofuryl in a randomized placebo-controlled double-blind study.
    Jung F; Wolf S; Kiesewetter H
    Arzneimittelforschung; 1989 Oct; 39(10):1277-80. PubMed ID: 2610721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study, using Doppler hemotachymetry, of the cerebral hemodynamic action of naftidrofuryl].
    Depresseux JC
    Rev Med Liege; 1979 Dec; 34(24):1007-10. PubMed ID: 550268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.